ImmunityBio
IBRX
$8.10
Share price
-3.57%
Change (1 day)
151.55%
Change (1 year)
Categories
Market capitalization of ImmunityBio (IBRX)
Market cap: $5.75 Billion
As of May 2024 ImmunityBio has a market cap of $5.75 Billion. This makes ImmunityBio the world's 2458th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ImmunityBio from 2021 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $5.75 B | 71.7% |
| 2023 | $3.35 B | 65.15% |
| 2022 | $2.02 B | -16.09% |
| 2021 | $2.41 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of ImmunityBio was reported to be:
$5.80 Billion
$5.80 Billion
$5.80 Billion
$5.80 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.62 B | -89.09% | 🇺🇸 USA |